FormWeb • pramlintide

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

pramlintide

pramlintide

Formulary Pharmacy consult required
Formulary Miscellaneous Programs

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
SymlinPen 120	SOLUTION, SUBCUTANEOUS	2,700 mcg/2.5 mL
SymlinPen 60	SOLUTION, SUBCUTANEOUS	1500 mcg/1.5 mL

Comments:

Not routinely stocked

Symlin medication guide

Symlin Protocol

Symlin Pharmacist Consult

Symlin Order Set

Symlin (pramlintide) Nursing Fact Sheet

SYMLIN vials have been discontinued by the manufacturer. The 60 and 120 pen injectors are now formulary agents. SYMLIN is an automatic pharmacist consult, diabetic educator consult required and endocrinology consult recommended.

Reviewed: July 27, 2005 (SYMLIN)

Reviewed: February 26, 2008 and December 13, 2011 (SYMLIN PEN)

REMS (SymlinPen): View FDA REMS Info

Last updated: Oct. 18, 2022

Black Box Warning: Pramlintide is used with insulin and has been associated with an increased risk of insulin-induced severe hypoglycemia, particularly in patients with type 1 diabetes.

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.